HEADER HYDROLASE 24-AUG-06 2I5G TITLE CRYSTAL STRCUTURE OF AMIDOHYDROLASE FROM PSEUDOMONAS AERUGINOSA COMPND MOL_ID: 1; COMPND 2 MOLECULE: AMIDOHYDROLASE; COMPND 3 CHAIN: A, B; COMPND 4 ENGINEERED: YES; COMPND 5 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: PSEUDOMONAS AERUGINOSA; SOURCE 3 ORGANISM_TAXID: 287; SOURCE 4 GENE: PAO1; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: BS-PSGX4(BS) KEYWDS NYSGXRC, NYSGXRC-9311A, PSI2, AMIDOHYDROLASE, STRUCTURAL GENOMICS, KEYWDS 2 PROTEIN STRUCTURE INITIATIVE, NEW YORK SGX RESEARCH CENTER FOR KEYWDS 3 STRUCTURAL GENOMICS, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR T.MIN,J.M.SAUDER,S.R.WASSERMAN,D.SMITH,S.K.BURLEY,L.SHAPIRO,NEW YORK AUTHOR 2 SGX RESEARCH CENTER FOR STRUCTURAL GENOMICS (NYSGXRC) REVDAT 7 20-OCT-21 2I5G 1 SEQADV REVDAT 6 03-FEB-21 2I5G 1 AUTHOR JRNL REVDAT 5 02-SEP-20 2I5G 1 SEQADV LINK REVDAT 4 14-NOV-18 2I5G 1 AUTHOR REVDAT 3 24-FEB-09 2I5G 1 VERSN REVDAT 2 03-OCT-06 2I5G 1 AUTHOR JRNL REVDAT 1 05-SEP-06 2I5G 0 JRNL AUTH T.MIN,J.M.SAUDER,S.R.WASSERMAN,D.SMITH,S.K.BURLEY,L.SHAPIRO JRNL TITL CRYSTAL STRUCTURE OF AMIDOHYDROLASE FROM PSEUDOMONAS JRNL TITL 2 AERUGINOSA JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 2.60 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.60 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.94 REMARK 3 DATA CUTOFF (SIGMA(F)) : 2.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 208685.000 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 86.9 REMARK 3 NUMBER OF REFLECTIONS : 43327 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.181 REMARK 3 FREE R VALUE : 0.250 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.800 REMARK 3 FREE R VALUE TEST SET COUNT : 2073 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.005 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.60 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.76 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 76.10 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 6047 REMARK 3 BIN R VALUE (WORKING SET) : 0.2100 REMARK 3 BIN FREE R VALUE : 0.2980 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.80 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 308 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.017 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5076 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 544 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 11.70 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 17.80 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 5.05000 REMARK 3 B22 (A**2) : -9.09000 REMARK 3 B33 (A**2) : 4.04000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 2.66000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.25 REMARK 3 ESD FROM SIGMAA (A) : 0.24 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.36 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.36 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.006 REMARK 3 BOND ANGLES (DEGREES) : 1.300 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 22.70 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.700 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : GROUP REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.30 REMARK 3 BSOL : 34.30 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : ION.PARAM REMARK 3 PARAMETER FILE 4 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : ION.TOP REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2I5G COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 25-AUG-06. REMARK 100 THE DEPOSITION ID IS D_1000039160. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 07-AUG-06 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 31-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97958 REMARK 200 MONOCHROMATOR : KOHZU HLD-4 DOUBLE CRYSTAL REMARK 200 OPTICS : KOHZU HLD-4 DOUBLE CRYSTAL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MAR CCD 165 MM REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 43327 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.600 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.2 REMARK 200 DATA REDUNDANCY : 5.500 REMARK 200 R MERGE (I) : 0.11900 REMARK 200 R SYM (I) : 0.11900 REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.60 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.69 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.5 REMARK 200 DATA REDUNDANCY IN SHELL : 5.50 REMARK 200 R MERGE FOR SHELL (I) : 0.27200 REMARK 200 R SYM FOR SHELL (I) : 0.27200 REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: SAD REMARK 200 SOFTWARE USED: SOLVE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 57.13 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.87 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M CACODYLATE, 22.5% PEG400, 0.2M REMARK 280 LISO4, PH 6.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 40.82200 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 75.30750 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 40.82200 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 75.30750 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO A 4 82.70 -67.53 REMARK 500 ALA A 5 -43.99 168.79 REMARK 500 ASP A 10 33.69 -86.26 REMARK 500 SER A 43 138.60 -174.44 REMARK 500 VAL A 44 -51.42 -140.67 REMARK 500 PHE A 48 -77.33 -55.03 REMARK 500 GLU A 100 -124.66 51.66 REMARK 500 ASN A 122 -47.73 67.80 REMARK 500 ASN A 125 -162.99 -110.63 REMARK 500 TYR A 179 76.44 -118.53 REMARK 500 HIS A 190 135.37 10.52 REMARK 500 HIS A 205 30.42 -92.29 REMARK 500 ASP A 250 40.46 77.88 REMARK 500 TYR A 269 -20.42 -152.40 REMARK 500 ALA A 270 -150.65 -75.74 REMARK 500 ILE A 285 58.76 -156.39 REMARK 500 LEU B 17 111.29 -169.35 REMARK 500 GLU B 28 -48.30 84.62 REMARK 500 VAL B 44 -40.33 -146.27 REMARK 500 PHE B 48 -86.23 -46.24 REMARK 500 ALA B 50 -48.96 121.30 REMARK 500 GLU B 100 -121.46 48.04 REMARK 500 ASN B 122 -51.18 67.83 REMARK 500 ASN B 125 -162.32 -121.80 REMARK 500 TYR B 132 -0.33 91.61 REMARK 500 ARG B 134 112.95 -38.47 REMARK 500 LYS B 164 -69.10 134.18 REMARK 500 HIS B 190 141.76 -177.12 REMARK 500 ALA B 215 -59.13 -28.86 REMARK 500 ILE B 222 11.77 -68.68 REMARK 500 ILE B 239 -61.24 -97.10 REMARK 500 LYS B 267 9.03 58.71 REMARK 500 TYR B 269 -17.15 -158.13 REMARK 500 ALA B 270 -125.96 -73.05 REMARK 500 THR B 274 -176.48 -174.39 REMARK 500 ILE B 285 38.97 -170.72 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: NYSGXRC-9311A RELATED DB: TARGETDB DBREF 2I5G A 3 326 UNP Q9HTG8 Q9HTG8_PSEAE 2 325 DBREF 2I5G B 3 326 UNP Q9HTG8 Q9HTG8_PSEAE 2 325 SEQADV 2I5G LEU A 2 UNP Q9HTG8 CLONING ARTIFACT SEQADV 2I5G MSE A 30 UNP Q9HTG8 MET 29 MODIFIED RESIDUE SEQADV 2I5G THR A 56 UNP Q9HTG8 ALA 55 ENGINEERED MUTATION SEQADV 2I5G MSE A 119 UNP Q9HTG8 MET 118 MODIFIED RESIDUE SEQADV 2I5G MSE A 149 UNP Q9HTG8 MET 148 MODIFIED RESIDUE SEQADV 2I5G MSE A 155 UNP Q9HTG8 MET 154 MODIFIED RESIDUE SEQADV 2I5G MSE A 213 UNP Q9HTG8 MET 212 MODIFIED RESIDUE SEQADV 2I5G MSE A 237 UNP Q9HTG8 MET 236 MODIFIED RESIDUE SEQADV 2I5G LYS A 300 UNP Q9HTG8 GLU 299 ENGINEERED MUTATION SEQADV 2I5G MSE A 303 UNP Q9HTG8 MET 302 MODIFIED RESIDUE SEQADV 2I5G MSE A 312 UNP Q9HTG8 MET 311 MODIFIED RESIDUE SEQADV 2I5G LEU B 2 UNP Q9HTG8 CLONING ARTIFACT SEQADV 2I5G MSE B 30 UNP Q9HTG8 MET 29 MODIFIED RESIDUE SEQADV 2I5G THR B 56 UNP Q9HTG8 ALA 55 ENGINEERED MUTATION SEQADV 2I5G MSE B 119 UNP Q9HTG8 MET 118 MODIFIED RESIDUE SEQADV 2I5G MSE B 149 UNP Q9HTG8 MET 148 MODIFIED RESIDUE SEQADV 2I5G MSE B 155 UNP Q9HTG8 MET 154 MODIFIED RESIDUE SEQADV 2I5G MSE B 213 UNP Q9HTG8 MET 212 MODIFIED RESIDUE SEQADV 2I5G MSE B 237 UNP Q9HTG8 MET 236 MODIFIED RESIDUE SEQADV 2I5G LYS B 300 UNP Q9HTG8 GLU 299 ENGINEERED MUTATION SEQADV 2I5G MSE B 303 UNP Q9HTG8 MET 302 MODIFIED RESIDUE SEQADV 2I5G MSE B 312 UNP Q9HTG8 MET 311 MODIFIED RESIDUE SEQRES 1 A 325 LEU SER PRO ALA GLU LEU HIS ALA ASP SER ILE VAL ILE SEQRES 2 A 325 ASP GLY LEU ILE ILE ALA LYS TRP ASN ARG GLU LEU PHE SEQRES 3 A 325 GLU ASP MSE ARG LYS GLY GLY LEU THR ALA ALA ASN CYS SEQRES 4 A 325 THR VAL SER VAL TRP GLU GLY PHE GLN ALA THR VAL ASN SEQRES 5 A 325 ASN ILE THR ALA SER ASN LYS LEU ILE ARG ASP ASN SER SEQRES 6 A 325 ASP LEU VAL ILE PRO VAL ARG SER THR ALA ASP ILE ARG SEQRES 7 A 325 LYS ALA LYS GLU GLN GLY LYS THR GLY ILE LEU TYR GLY SEQRES 8 A 325 PHE GLN ASN ALA HIS ALA PHE GLU ASP GLN ILE GLY TYR SEQRES 9 A 325 VAL GLU VAL PHE LYS GLN LEU GLY VAL GLY ILE VAL GLN SEQRES 10 A 325 MSE CYS TYR ASN THR GLN ASN LEU VAL GLY THR GLY CYS SEQRES 11 A 325 TYR GLU ARG ASP GLY GLY LEU SER GLY PHE GLY ARG GLU SEQRES 12 A 325 ILE VAL ALA GLU MSE ASN ARG VAL GLY ILE MSE CYS ASP SEQRES 13 A 325 LEU SER HIS VAL GLY SER LYS THR SER GLU GLU VAL ILE SEQRES 14 A 325 LEU GLU SER LYS LYS PRO VAL CYS TYR SER HIS CYS LEU SEQRES 15 A 325 PRO SER GLY LEU LYS GLU HIS PRO ARG ASN LYS SER ASP SEQRES 16 A 325 GLU GLU LEU LYS PHE ILE ALA ASP HIS GLY GLY PHE VAL SEQRES 17 A 325 GLY VAL THR MSE PHE ALA PRO PHE LEU LYS LYS GLY ILE SEQRES 18 A 325 ASP SER THR ILE ASP ASP TYR ALA GLU ALA ILE GLU TYR SEQRES 19 A 325 VAL MSE ASN ILE VAL GLY GLU ASP ALA ILE GLY ILE GLY SEQRES 20 A 325 THR ASP PHE THR GLN GLY HIS GLY HIS ASP PHE PHE GLU SEQRES 21 A 325 TRP LEU THR HIS ASP LYS GLY TYR ALA ARG ARG LEU THR SEQRES 22 A 325 ASN PHE GLY LYS ILE VAL ASN PRO LEU GLY ILE ARG THR SEQRES 23 A 325 VAL GLY GLU PHE PRO ASN LEU THR GLU THR LEU LEU LYS SEQRES 24 A 325 ARG GLY MSE PRO GLU ARG VAL VAL ARG LYS VAL MSE GLY SEQRES 25 A 325 GLU ASN TRP VAL ARG VAL LEU ARG ASP VAL TRP GLY GLU SEQRES 1 B 325 LEU SER PRO ALA GLU LEU HIS ALA ASP SER ILE VAL ILE SEQRES 2 B 325 ASP GLY LEU ILE ILE ALA LYS TRP ASN ARG GLU LEU PHE SEQRES 3 B 325 GLU ASP MSE ARG LYS GLY GLY LEU THR ALA ALA ASN CYS SEQRES 4 B 325 THR VAL SER VAL TRP GLU GLY PHE GLN ALA THR VAL ASN SEQRES 5 B 325 ASN ILE THR ALA SER ASN LYS LEU ILE ARG ASP ASN SER SEQRES 6 B 325 ASP LEU VAL ILE PRO VAL ARG SER THR ALA ASP ILE ARG SEQRES 7 B 325 LYS ALA LYS GLU GLN GLY LYS THR GLY ILE LEU TYR GLY SEQRES 8 B 325 PHE GLN ASN ALA HIS ALA PHE GLU ASP GLN ILE GLY TYR SEQRES 9 B 325 VAL GLU VAL PHE LYS GLN LEU GLY VAL GLY ILE VAL GLN SEQRES 10 B 325 MSE CYS TYR ASN THR GLN ASN LEU VAL GLY THR GLY CYS SEQRES 11 B 325 TYR GLU ARG ASP GLY GLY LEU SER GLY PHE GLY ARG GLU SEQRES 12 B 325 ILE VAL ALA GLU MSE ASN ARG VAL GLY ILE MSE CYS ASP SEQRES 13 B 325 LEU SER HIS VAL GLY SER LYS THR SER GLU GLU VAL ILE SEQRES 14 B 325 LEU GLU SER LYS LYS PRO VAL CYS TYR SER HIS CYS LEU SEQRES 15 B 325 PRO SER GLY LEU LYS GLU HIS PRO ARG ASN LYS SER ASP SEQRES 16 B 325 GLU GLU LEU LYS PHE ILE ALA ASP HIS GLY GLY PHE VAL SEQRES 17 B 325 GLY VAL THR MSE PHE ALA PRO PHE LEU LYS LYS GLY ILE SEQRES 18 B 325 ASP SER THR ILE ASP ASP TYR ALA GLU ALA ILE GLU TYR SEQRES 19 B 325 VAL MSE ASN ILE VAL GLY GLU ASP ALA ILE GLY ILE GLY SEQRES 20 B 325 THR ASP PHE THR GLN GLY HIS GLY HIS ASP PHE PHE GLU SEQRES 21 B 325 TRP LEU THR HIS ASP LYS GLY TYR ALA ARG ARG LEU THR SEQRES 22 B 325 ASN PHE GLY LYS ILE VAL ASN PRO LEU GLY ILE ARG THR SEQRES 23 B 325 VAL GLY GLU PHE PRO ASN LEU THR GLU THR LEU LEU LYS SEQRES 24 B 325 ARG GLY MSE PRO GLU ARG VAL VAL ARG LYS VAL MSE GLY SEQRES 25 B 325 GLU ASN TRP VAL ARG VAL LEU ARG ASP VAL TRP GLY GLU MODRES 2I5G MSE A 30 MET SELENOMETHIONINE MODRES 2I5G MSE A 119 MET SELENOMETHIONINE MODRES 2I5G MSE A 149 MET SELENOMETHIONINE MODRES 2I5G MSE A 155 MET SELENOMETHIONINE MODRES 2I5G MSE A 213 MET SELENOMETHIONINE MODRES 2I5G MSE A 237 MET SELENOMETHIONINE MODRES 2I5G MSE A 303 MET SELENOMETHIONINE MODRES 2I5G MSE A 312 MET SELENOMETHIONINE MODRES 2I5G MSE B 30 MET SELENOMETHIONINE MODRES 2I5G MSE B 119 MET SELENOMETHIONINE MODRES 2I5G MSE B 149 MET SELENOMETHIONINE MODRES 2I5G MSE B 155 MET SELENOMETHIONINE MODRES 2I5G MSE B 213 MET SELENOMETHIONINE MODRES 2I5G MSE B 237 MET SELENOMETHIONINE MODRES 2I5G MSE B 303 MET SELENOMETHIONINE MODRES 2I5G MSE B 312 MET SELENOMETHIONINE HET MSE A 30 8 HET MSE A 119 8 HET MSE A 149 8 HET MSE A 155 8 HET MSE A 213 8 HET MSE A 237 8 HET MSE A 303 8 HET MSE A 312 8 HET MSE B 30 8 HET MSE B 119 8 HET MSE B 149 8 HET MSE B 155 8 HET MSE B 213 8 HET MSE B 237 8 HET MSE B 303 8 HET MSE B 312 8 HETNAM MSE SELENOMETHIONINE FORMUL 1 MSE 16(C5 H11 N O2 SE) FORMUL 3 HOH *544(H2 O) HELIX 1 1 ALA A 5 ASP A 10 1 6 HELIX 2 2 ASN A 23 GLY A 33 1 11 HELIX 3 3 GLY A 47 ASN A 65 1 19 HELIX 4 4 SER A 74 GLN A 84 1 11 HELIX 5 5 ASN A 95 GLU A 100 5 6 HELIX 6 6 ILE A 103 LEU A 112 1 10 HELIX 7 7 SER A 139 GLY A 153 1 15 HELIX 8 8 GLY A 162 SER A 173 1 12 HELIX 9 9 SER A 195 HIS A 205 1 11 HELIX 10 10 PHE A 214 LEU A 218 5 5 HELIX 11 11 LYS A 220 SER A 224 5 5 HELIX 12 12 THR A 225 GLY A 241 1 17 HELIX 13 13 GLY A 256 HIS A 265 1 10 HELIX 14 14 ASP A 266 TYR A 269 5 4 HELIX 15 15 THR A 287 GLU A 290 5 4 HELIX 16 16 PHE A 291 ARG A 301 1 11 HELIX 17 17 PRO A 304 GLY A 313 1 10 HELIX 18 18 GLY A 313 GLY A 325 1 13 HELIX 19 19 SER B 3 SER B 11 1 9 HELIX 20 20 GLU B 25 GLY B 33 1 9 HELIX 21 21 GLY B 47 ASN B 65 1 19 HELIX 22 22 SER B 74 GLY B 85 1 12 HELIX 23 23 ASN B 95 GLU B 100 5 6 HELIX 24 24 ILE B 103 LEU B 112 1 10 HELIX 25 25 SER B 139 GLY B 153 1 15 HELIX 26 26 LYS B 164 SER B 173 1 10 HELIX 27 27 SER B 195 HIS B 205 1 11 HELIX 28 28 PHE B 214 LEU B 218 5 5 HELIX 29 29 LYS B 220 SER B 224 5 5 HELIX 30 30 THR B 225 GLY B 241 1 17 HELIX 31 31 GLY B 256 HIS B 265 1 10 HELIX 32 32 ASP B 266 TYR B 269 5 4 HELIX 33 33 THR B 287 GLU B 290 5 4 HELIX 34 34 PHE B 291 ARG B 301 1 11 HELIX 35 35 PRO B 304 GLY B 313 1 10 HELIX 36 36 GLY B 313 GLY B 325 1 13 SHEET 1 A 4 ILE A 14 ILE A 18 0 SHEET 2 A 4 ALA A 37 THR A 41 1 O ASN A 39 N ASP A 15 SHEET 3 A 4 THR A 87 PHE A 93 1 O GLY A 92 N CYS A 40 SHEET 4 A 4 VAL A 69 PRO A 71 1 N ILE A 70 O ILE A 89 SHEET 1 B 5 ILE A 14 ILE A 18 0 SHEET 2 B 5 ALA A 37 THR A 41 1 O ASN A 39 N ASP A 15 SHEET 3 B 5 THR A 87 PHE A 93 1 O GLY A 92 N CYS A 40 SHEET 4 B 5 VAL A 114 GLN A 118 1 O GLN A 118 N PHE A 93 SHEET 5 B 5 MSE A 155 ASP A 157 1 O MSE A 155 N VAL A 117 SHEET 1 C 3 CYS A 178 CYS A 182 0 SHEET 2 C 3 PHE A 208 VAL A 211 1 O GLY A 210 N TYR A 179 SHEET 3 C 3 ILE A 245 ILE A 247 1 O GLY A 246 N VAL A 211 SHEET 1 D 4 VAL B 13 ILE B 18 0 SHEET 2 D 4 LEU B 35 THR B 41 1 O ASN B 39 N ILE B 18 SHEET 3 D 4 THR B 87 PHE B 93 1 O GLY B 88 N THR B 36 SHEET 4 D 4 VAL B 69 PRO B 71 1 N ILE B 70 O ILE B 89 SHEET 1 E 5 VAL B 13 ILE B 18 0 SHEET 2 E 5 LEU B 35 THR B 41 1 O ASN B 39 N ILE B 18 SHEET 3 E 5 THR B 87 PHE B 93 1 O GLY B 88 N THR B 36 SHEET 4 E 5 ILE B 116 GLN B 118 1 O ILE B 116 N PHE B 93 SHEET 5 E 5 MSE B 155 ASP B 157 1 O MSE B 155 N VAL B 117 SHEET 1 F 3 CYS B 178 CYS B 182 0 SHEET 2 F 3 PHE B 208 VAL B 211 1 O GLY B 210 N TYR B 179 SHEET 3 F 3 ILE B 245 ILE B 247 1 O GLY B 246 N VAL B 211 LINK C ASP A 29 N MSE A 30 1555 1555 1.33 LINK C MSE A 30 N ARG A 31 1555 1555 1.33 LINK C GLN A 118 N MSE A 119 1555 1555 1.33 LINK C MSE A 119 N CYS A 120 1555 1555 1.33 LINK C GLU A 148 N MSE A 149 1555 1555 1.33 LINK C MSE A 149 N ASN A 150 1555 1555 1.33 LINK C ILE A 154 N MSE A 155 1555 1555 1.33 LINK C MSE A 155 N CYS A 156 1555 1555 1.33 LINK C THR A 212 N MSE A 213 1555 1555 1.33 LINK C MSE A 213 N PHE A 214 1555 1555 1.33 LINK C VAL A 236 N MSE A 237 1555 1555 1.33 LINK C MSE A 237 N ASN A 238 1555 1555 1.33 LINK C GLY A 302 N MSE A 303 1555 1555 1.33 LINK C MSE A 303 N PRO A 304 1555 1555 1.34 LINK C VAL A 311 N MSE A 312 1555 1555 1.33 LINK C MSE A 312 N GLY A 313 1555 1555 1.33 LINK C ASP B 29 N MSE B 30 1555 1555 1.33 LINK C MSE B 30 N ARG B 31 1555 1555 1.34 LINK C GLN B 118 N MSE B 119 1555 1555 1.33 LINK C MSE B 119 N CYS B 120 1555 1555 1.33 LINK C GLU B 148 N MSE B 149 1555 1555 1.33 LINK C MSE B 149 N ASN B 150 1555 1555 1.33 LINK C ILE B 154 N MSE B 155 1555 1555 1.33 LINK C MSE B 155 N CYS B 156 1555 1555 1.33 LINK C THR B 212 N MSE B 213 1555 1555 1.33 LINK C MSE B 213 N PHE B 214 1555 1555 1.33 LINK C VAL B 236 N MSE B 237 1555 1555 1.33 LINK C MSE B 237 N ASN B 238 1555 1555 1.33 LINK C GLY B 302 N MSE B 303 1555 1555 1.32 LINK C MSE B 303 N PRO B 304 1555 1555 1.35 LINK C VAL B 311 N MSE B 312 1555 1555 1.33 LINK C MSE B 312 N GLY B 313 1555 1555 1.33 CRYST1 81.644 150.615 68.828 90.00 97.94 90.00 C 1 2 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012248 0.000000 0.001708 0.00000 SCALE2 0.000000 0.006639 0.000000 0.00000 SCALE3 0.000000 0.000000 0.014670 0.00000